학술논문

Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
Document Type
Journal
Source
ANNALS OF THE RHEUMATIC DISEASES; JUL 2019, 78 7, p899-p907, 9p.
Subject
Language
English
ISSN
14682060